AIM ImmunoTech Inc. Files 8-K Amid Listing Concerns
Ticker: AIM · Form: 8-K · Filed: Jun 12, 2025 · CIK: 946644
| Field | Detail |
|---|---|
| Company | Aim Immunotech INC. (AIM) |
| Form Type | 8-K |
| Filed Date | Jun 12, 2025 |
| Risk Level | high |
| Sentiment | bearish |
Sentiment: bearish
Topics: delisting, listing-rules, regulatory
TL;DR
AIM ImmunoTech might be delisted - filing shows listing rule issues.
AI Summary
AIM ImmunoTech Inc. filed an 8-K on May 29, 2025, reporting a notice of delisting or failure to satisfy a continued listing rule. The company also filed amendments to its articles of incorporation or bylaws and reported other events. The filing was made on June 12, 2025.
Why It Matters
This filing indicates potential issues with AIM ImmunoTech's continued listing on an exchange, which could impact its stock price and investor confidence.
Risk Assessment
Risk Level: high — The filing explicitly mentions a 'Notice of Delisting or Failure to Satisfy a Continued Listing Rule', indicating significant risk to the company's stock exchange status.
Key Players & Entities
- AIM ImmunoTech Inc. (company) — Registrant
- May 29, 2025 (date) — Date of earliest event reported
- June 12, 2025 (date) — Filing date
- Delaware (jurisdiction) — State of incorporation
- 001-27072 (identifier) — Commission File Number
FAQ
What specific listing rule has AIM ImmunoTech Inc. failed to satisfy?
The filing does not specify the exact listing rule that has been failed, only that a notice of delisting or failure to satisfy a continued listing rule has been issued.
What are the potential consequences of failing to satisfy a continued listing rule?
Failure to satisfy a continued listing rule can lead to the delisting of the company's securities from the stock exchange.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing occurred on May 29, 2025.
What other items are reported in this 8-K filing besides the delisting notice?
This 8-K filing also reports on Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, and Other Events.
What is the principal executive office address for AIM ImmunoTech Inc.?
The principal executive office address for AIM ImmunoTech Inc. is 2117 SW Highway 484, Ocala FL 34473.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 12, 2025 regarding AIM ImmunoTech Inc. (AIM).